We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Multiple Ascending Dose (MDX1105-01) (Anti-PDL1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00729664
Recruitment Status : Completed
First Posted : August 7, 2008
Last Update Posted : September 7, 2015
Information provided by (Responsible Party):
Bristol-Myers Squibb